18F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer

被引:72
作者
Chen, Long-Bang [1 ]
Tong, In-Long
Song, Hai-Zhu
Zhu, Hong
Wang, Yu-Cai
机构
[1] Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing 210002, Peoples R China
[2] Nanjing Univ, Sch Med, Jinling Hosp, Dept Nucl Med, Nanjing 210002, Peoples R China
关键词
D O I
10.3748/wjg.v13.i37.5025
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To evaluate the value of F-18-DG PET/CT in detecting recurrence and/or metastasis of colorectal cancer (CRC). METHODS: Combined visual analysis with semiquantitative analysis, the F-18-DG PET/CT whole-body imaging results and the corresponding clinical data of 68 postoperative CRC patients including 48 male and 20 female with average age of 58.1 were analyzed retrospectively. RESULTS: Recurrence and/or metastasis were confirmed in 56 patients in the clinical follow-up after the PET/CT imaging. The sensitivity of PET/CT diagnosis of CRC recurrence and/or metastasis was 94.6%, and the specificity was 83.3%. The positive predictive value (PPV) was 96.4% and the negative predictive value (NPV) was 76.9%. PET/CT imaging detected one or more occult malignant lesions in 8 cases where abdominal/pelvic CT and/or ultrasonography showed negative findings, and also detected more lesions than CT or ultrasonography did in 30.4% (17/56) cases. Recurrence and/or metastasis was detected in 91.7% (22/24) cases with elevated serum CEA levels by F-18-DG PET/CT imaging. CONCLUSION: F-18-DG PET/CT could detect the recurrence and/or metastasis of CRC with high sensitivity and specificity. (c) 2007 WJG. All rights reserved.
引用
收藏
页码:5025 / 5029
页数:5
相关论文
共 15 条
[1]
Evolution in the treatment of metastatic colorectal carcinoma of the liver [J].
Ariyan, Charlotte E. ;
Salem, Ronald R. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (20) :3253-3258
[2]
The hope for today - The promise for tomorrow: Will oncologists meet the challenge? [J].
Benson, Al B., III ;
Lurie, Robert H. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (16) :2156-2158
[3]
Cohade C, 2003, J NUCL MED, V44, P1797
[4]
Delbeke D, 1997, J NUCL MED, V38, P1196
[5]
Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline [J].
Desch, CE ;
Benson, A ;
Somerfield, MR ;
Flynn, PJ ;
Krause, C ;
Loprinzi, CL ;
Minsky, BD ;
Pfister, DG ;
Virgo, KS ;
Petrelli, NJ .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (33) :8512-8519
[6]
Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer [J].
Fernandes, Luis C. ;
Kim, Su B. ;
Saad, Sarhan S. ;
Matos, Delcio .
WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (24) :3891-3894
[7]
Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer [J].
Gearhart, SL ;
Frassica, D ;
Rosen, R ;
Choti, M ;
Schulick, R ;
Wahl, R .
ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (03) :397-404
[8]
Huebner RH, 2000, J NUCL MED, V41, P1177
[9]
2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography imaging evaluation of esophageal cancer [J].
Jadvar, Hossein ;
Henderson, Robert W. ;
Conti, Peter S. .
MOLECULAR IMAGING AND BIOLOGY, 2006, 8 (03) :193-200
[10]
Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): A meta-analysis [J].
Kinkel, K ;
Lu, Y ;
Both, M ;
Warren, RS ;
Thoeni, RF .
RADIOLOGY, 2002, 224 (03) :748-756